ArticleFrontiers in oncology2026
Factors requiring adaptive re-planning in carbon ion radiotherapy for head and neck cancers.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The anatomical changes during carbon ion radiotherapy (CIRT) for head and neck cancers frequently require plan adaptations with adaptive re-planning. However, the details of the anatomical changes and their rates are not clear. The purpose of this study was to retrospectively evaluate the factors that require re-planning during CIRT for head and neck cancers. Methods: Thirty-seven patients who underwent 146 computed tomography (CT) scans and CIRT for head and neck cancers were evaluated retrospectively. To evaluate the re-planning situation, the frequency of the plan adaptation, reasons for plan adaptations, and causes of dose-distribution distortion were evaluated. Dose distributions were evaluated for two cases in which re-planning was carried out due to changes in tumor size and density on the beam path. Results: The main cause for dose-distribution distortion was a change in tumor size for 11 of 13 patients who underwent plan adaptation. Of the tumor-size changes, 64% were due to tumor expansion. For two patients, adaptive re-planning on weekly CT images resulted in a dose distribution equivalent to the original treatment plan in terms of target coverage and sparing of organs at risk. Conclusion: In CIRT for head and neck cancers, the main cause of dose-distribution distortion requiring re-planning was an increase in tumor size soon after treatment initiation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.